婴儿发作综合征:机制和治疗方法
1Division of Pediatric Neurology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
概括
婴儿发作综合征 (IESS) 是一种复杂的,神经生物学不清楚. 本评论探讨了命名,EEG和动物模型,以促进对这种发育性脑病变的理解和治疗.
科学领域:
- 神经学 神经学
- 发育神经科学的发展神经科学.
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 婴儿发作综合征 (IESS) 是一种严重的发育和脑病.
- 它呈现出独特的形形象学,多种病因 (结构性,遗传性,代谢性) 和特征性的EEG模式 (低节律症,电).
- 尽管已知特征和动物模型,但其神经生物学基础仍然不明,阻碍了新疗法开发.
研究的目的:
- 在IESS中解决基本的临床和机制问题.
- 促进人们对IESS病理生理学的更好理解.
- 引导开发替代治疗策略的指导.
主要方法:
- 本评论回顾了关于IESS的现有文献和研究.
- 它侧重于三个关键方面:命名,脑电图 (EEG) 发现和新兴的动物模型.
- 讨论旨在刺激对IESS机制的批判性思考.
主要成果:
- 评论强调了在IESS研究中需要更清晰的命名法.
- 它强调了特征性EEG模式在诊断和理解中的重要性.
- 新兴的动物模型为IESS病理生理学提供了潜在的见解.
结论:
- 更深入地了解IESS神经生物学对于推进治疗选择至关重要.
- 对命名,EEG和动物模型的进一步研究是有必要的.
- 这项工作旨在激发改善IESS管理的基本问题.
相关概念视频
Spasmolytic Agents: Chemical Classification
1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
790
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
790
Antiepileptic Drugs: Glutamate Antagonists
857
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
857
Skeletal Muscle Relaxants: Therapeutic Uses
856
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
856


